Cancer Epidemiology Biomarkers & Prevention, Vol 1, Issue 1 57-60, Copyright © 1991 by American Association for Cancer Research

ARTICLES

Classification of aberrant crypt foci and microadenomas in human colon

L Roncucci, A Medline and WR Bruce
Department of Medical Biophysics, University of Toronto, Ontario, Canada.

Aberrant crypt foci (ACF) can be observed and quantified on the mucosal surface of formalin-fixed human colon resections after staining with methylene blue. To determine whether these ACF could be identified in fresh tissue, 10 colon resections were collected after surgery for colorectal cancer. Unfixed and fixed flat normal colonic mucosa from each colon were scored for ACF under a dissecting microscope after methylene blue staining. The number of ACF per cm2 and the average number of crypts per foci correlated highly in unfixed and fixed mucosa (r = 0.93 and 0.78, respectively). A significantly higher frequency of lesions was found in left-sided compared to right-sided colon resections. To determine whether the topographic features of the ACF gave an indication of the histological appearance, 68 specimens containing ACF or normal mucosa were examined histologically. The presence of slit-like lumen in the crypts of ACF on the mucosal surface correlated with the presence of dysplasia at histology, thus identifying microadenomas. These two observations suggest that the topographic classification of ACF in vivo could be used to distinguish microadenomas, a putative precursor lesion of colon cancer.

This article has been cited by other articles:

				P. Lance and S. R. Hamilton Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention Cancer Prevention Research, June 1, 2008; 1(1): 4 - 8. [Full Text] [PDF]

				H. Xiao, X. Hao, B. Simi, J. Ju, H. Jiang, B. S. Reddy, and C. S. Yang Green tea polyphenols inhibit colorectal aberrant crypt foci (ACF) formation and prevent oncogenic changes in dysplastic ACF in azoxymethane-treated F344 rats Carcinogenesis, January 1, 2008; 29(1): 113 - 119. [Abstract] [Full Text] [PDF]

				E. M. Schmelz, H. Xu, R. Sengupta, J. Du, S. Banerjee, F. H. Sarkar, A. K. Rishi, and A. P.N. Majumdar Regression of Early and Intermediate Stages of Colon Cancer by Targeting Multiple Members of the EGFR Family with EGFR-Related Protein Cancer Res., June 1, 2007; 67(11): 5389 - 5396. [Abstract] [Full Text] [PDF]

				G. Cohen, R. Mustafi, A. Chumsangsri, N. Little, J. Nathanson, S. Cerda, S. Jagadeeswaran, U. Dougherty, L. Joseph, J. Hart, et al. Epidermal Growth Factor Receptor Signaling Is Up-regulated in Human Colonic Aberrant Crypt Foci Cancer Res., June 1, 2006; 66(11): 5656 - 5664. [Abstract] [Full Text] [PDF]

				S. R. Zamuner, A. W. Bak, P. R. Devchand, and J. L. Wallace Predisposition to Colorectal Cancer in Rats with Resolved Colitis: Role of Cyclooxygenase-2-Derived Prostaglandin D2 Am. J. Pathol., November 1, 2005; 167(5): 1293 - 1300. [Abstract] [Full Text] [PDF]

				G. Caderni, A. P. Femia, A. Giannini, A. Favuzza, C. Luceri, M. Salvadori, and P. Dolara Identification of Mucin-depleted Foci in the Unsectioned Colon of Azoxymethane-treated Rats: Correlation with Carcinogenesis Cancer Res., May 15, 2003; 63(10): 2388 - 2392. [Abstract] [Full Text] [PDF]

				H. Bernstein, H. Holubec, J. A. Warneke, H. Garewal, D. L. Earnest, C. M. Payne, D. J. Roe, H. Cui, E. L. Jacobson, and C. Bernstein Patchy Field Defects of Apoptosis Resistance and Dedifferentiation in Flat Mucosa of Colon Resections From Colon Cancer Patients Ann. Surg. Oncol., June 1, 2002; 9(5): 505 - 517. [Abstract] [Full Text] [PDF]

				M Anti, A Armuzzi, S Morini, E Iascone, G Pignataro, C Coco, R Lorenzetti, M Paolucci, M Covino, A Gasbarrini, et al. Severe imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomas Gut, February 1, 2001; 48(2): 238 - 246. [Abstract] [Full Text] [PDF]

				P. J. Rijken, W. G. Timmer, A. J. van de Kooij, I. M. van Benschop, S. A. Wiseman, M. Meijers, and L. B.M. Tijburg Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats Carcinogenesis, December 1, 1999; 20(12): 2267 - 2272. [Abstract] [Full Text] [PDF]

				C. M. Fenoglio-Preiser and A. Noffsinger Review Article: Aberrant Crypt Foci: A Review Toxicol Pathol, November 1, 1999; 27(6): 632 - 642. [PDF]

				T. Takayama, S. Katsuki, Y. Takahashi, M. Ohi, S. Nojiri, S. Sakamaki, J. Kato, K. Kogawa, H. Miyake, and Y. Niitsu Aberrant Crypt Foci of the Colon as Precursors of Adenoma and Cancer N. Engl. J. Med., October 29, 1998; 339(18): 1277 - 1284. [Abstract] [Full Text] [PDF]

				T. P. Pretlow and T. G. Pretlow Putative Preneoplastic Changes Identified by Enzyme Histochemical and Immunohistochemical Techniques J. Histochem. Cytochem., May 1, 1998; 46(5): 577 - 584. [Abstract] [Full Text]